Determination of Paraoxonase 1 Status Without the Use of Toxic Organophosphate Substrates

Circulation: Cardiovascular Genetics
doi 10.1161/circgenetics.108.811638
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Paraoxonase 1 Status in the Thai Population

Journal of Human Genetics
Genetics
2005English

Engineered Recombinant Human Paraoxonase 1 (rHuPON1) Purified From Escherichia Coli Protects Against Organophosphate Poisoning

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

1182 Total Oxidative Status, Total Anti-Oxidative Status and Paraoxonase-1 Levels in Neonatal Sepsis

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2012English

Regulation of Hepatic Paraoxonase-1 Expression

Journal of Lipids
Biochemistry
2012English

Determination of Organophosphate Estersin Cigarettes and Cigarette Smoke

Modern Environmental Science and Engineering
2016English

The Determination of the Status of Emergency Department Use by Elderly Patients and of the Indicators for Ambulance Use

Turk Geriatri Dergisi
GerontologyGeriatrics
2018English

Determination and Prediction of the Binding Interaction Between Organophosphate Flame Retardants and P53

Chemical Research in Toxicology
MedicineToxicology
2014English

The Role of Paraoxonase 1 in Regulating HDL Functionality During Aging

Canadian Journal of Physiology and Pharmacology
MedicinePhysiologyPharmacology
2017English

Toxic Epidermal Necrolysis (TEN) Associated With the Use of Nivolumab (PD-1 Inhibitor) for Lymphoma

JAAD Case Reports
Dermatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy